SUNESIS PHARMACEUTICALS INC Uncategorized Contracts & Agreements

Executive Engagement Agreement by and between the Company and Darrel P. Cohen, dated August 7, 2023 (Filed With SEC on November 9, 2023)

Open Market Sale AgreementSM, dated May 28, 2021, by and between Viracta Therapeutics, Inc. and Jefferies LLC (Filed With SEC on May 28, 2021)

Form of Lock-Up Agreement, dated November 29, 2020 (Filed With SEC on November 30, 2020)

Form of Viracta Therapeutics, Inc. Support Agreement, dated November 29, 2020 (Filed With SEC on November 30, 2020)

Form of Sunesis Pharmaceuticals, Inc. Support Agreement, dated November 29, 2020 (Filed With SEC on November 30, 2020)

Deferral Agreement, dated April 2, 2020, by and between the Registrant and Silicon Valley Bank (Filed With SEC on May 7, 2020)

SUNESIS PHARMACEUTICALS, INC. A Delaware Corporation (Filed With SEC on October 19, 2016)

SUNESIS PHARMACEUTICALS, INC. A Delaware Corporation (Filed With SEC on December 16, 2015)

FIFTH AGREEMENT REGARDING PRIVATE PLACEMENT OF SECURITIES OF SUNESIS PHARMACEUTICALS, INC. (Filed With SEC on February 3, 2012)

SUNESIS PHARMACEUTICALS, INC. (Filed With SEC on March 29, 2011)

THIRD AGREEMENT REGARDING PRIVATE PLACEMENT OF SECURITIES OF SUNESIS PHARMACEUTICALS, INC. (Filed With SEC on January 21, 2010)

SECOND AGREEMENT REGARDING PRIVATE PLACEMENT OF SECURITIES OF SUNESIS PHARMACEUTICALS, INC. (Filed With SEC on November 2, 2009)

AGREEMENT REGARDING PRIVATE PLACEMENT OF SECURITIES OF (Filed With SEC on July 2, 2009)

SECONDAMENDED AND RESTATED EXECUTIVESEVERANCE BENEFITS AGREEMENT (Filed With SEC on April 3, 2009)

AMENDEDAND RESTATED EXECUTIVESEVERANCE BENEFITS AGREEMENT (Filed With SEC on April 3, 2009)

Acceptance of Option Amendment (Filed With SEC on August 7, 2008)

EXHIBIT A DESCRIPTION OF PREMISES (Filed With SEC on December 23, 2004)

PROMISSORYNOTE (Filed With SEC on December 23, 2004)

SUNESISPHARMACEUTICALS, INC. INDEMNIFICATIONAGREEMENT (Filed With SEC on December 23, 2004)